Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator
Status:
NOT_YET_RECRUITING
Trial end date:
2024-07-28
Target enrollment:
Participant gender:
Summary
The study is to compare the rate and extent of absorption of a generic formulation with that of a reference for mulation when given as equal labeled dose. The study will be randomized, open-label, single dose, two way crossover design with two-period, two-treatment and two-sequence under fed condition and at least 7 days washout period between the doses.